MVision
| File:Mvision-ai-logo.png | |
| ISIN | 🆔 |
|---|---|
| Industry | Radiation therapy, artificial intelligence |
| Founded 📆 | 2017 |
| Founder 👔 | |
| Headquarters 🏙️ | , Finland |
Area served 🗺️ | |
| Members | |
Number of employees | |
| 🌐 Website | mvision |
| 📇 Address | |
| 📞 telephone | |
MVision is a Finnish company using artificial intelligence to improve cancer radiation therapy. MVision's software helps clinicians to draw up a radiation treatment plan for cancer patients. It is used for prostate cancer, and is expected to be functional for head and neck, and breast cancers. The software has been deployed in Turku University Hospital and the Docrates Cancer Center in Helsinki.
The company was founded in 2017, and in 2018 raised €620,000 in pre-seed funding from Icebreaker.vc, Nuard Ventures, Asko Schrey and Otto Söderlund, as well as Business Finland.[1]
References[edit]
- ↑ "MVision AI secures pre-seed investment". Good News from Finland. 23 May 2018.
External links[edit]
 | This Finnish corporation or company article is a stub. You can help EverybodyWiki by expanding it. |
This article "MVision" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:MVision. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
